Publication | Open Access
Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials
61
Citations
16
References
2019
Year
No safety concerns arose, supporting the favorable benefit-risk profile of RZV.
| Year | Citations | |
|---|---|---|
Page 1
Page 1